145 related articles for article (PubMed ID: 29978331)
1. FGFR1:TACC1 fusion is a frequent event in molecularly defined extraventricular neurocytoma.
Sievers P; Stichel D; Schrimpf D; Sahm F; Koelsche C; Reuss DE; Wefers AK; Reinhardt A; Huang K; Ebrahimi A; Hou Y; Pajtler KW; Pfister SM; Hasselblatt M; Stummer W; Schick U; Hartmann C; Hagel C; Staszewski O; Reifenberger G; Beschorner R; Coras R; Keyvani K; Kohlhof P; Diomedi-Camassei F; Herold-Mende C; Giangaspero F; Rushing E; Giannini C; Korshunov A; Jones DTW; von Deimling A
Acta Neuropathol; 2018 Aug; 136(2):293-302. PubMed ID: 29978331
[TBL] [Abstract][Full Text] [Related]
2. Intraventricular central neurocytoma molecularly defined as extraventricular neurocytoma: a case representing the discrepancy between clinicopathological and molecular classifications.
Sato D; Takami H; Takayanagi S; Ikemura M; Matsuura R; Tanaka S; Saito N
Brain Tumor Pathol; 2023 Oct; 40(4):230-234. PubMed ID: 37695397
[TBL] [Abstract][Full Text] [Related]
3. Two novel tumours with NTRK2 fusion in the methylation class of extraventricular neurocytomas, including one intraventricular.
Uro-Coste E; Tauziede-Espariat A; Dubucs C; Chiforeanu DC; Siegfried A; Nicaise Y; Bauchet L; Riffaud L; Bielle F; Vasiljevic A; Appay R; Evrard S; Varlet P; Rigau V;
Brain Pathol; 2024 May; 34(3):e13223. PubMed ID: 37994695
[TBL] [Abstract][Full Text] [Related]
4. Transforming fusions of FGFR and TACC genes in human glioblastoma.
Singh D; Chan JM; Zoppoli P; Niola F; Sullivan R; Castano A; Liu EM; Reichel J; Porrati P; Pellegatta S; Qiu K; Gao Z; Ceccarelli M; Riccardi R; Brat DJ; Guha A; Aldape K; Golfinos JG; Zagzag D; Mikkelsen T; Finocchiaro G; Lasorella A; Rabadan R; Iavarone A
Science; 2012 Sep; 337(6099):1231-5. PubMed ID: 22837387
[TBL] [Abstract][Full Text] [Related]
5. FGFR-TACC gene fusions in human glioma.
Lasorella A; Sanson M; Iavarone A
Neuro Oncol; 2017 Apr; 19(4):475-483. PubMed ID: 27852792
[TBL] [Abstract][Full Text] [Related]
6. Pediatric atypical extraventricular neurocytoma: Clinical features and survival outcomes.
Zhang L; Fang S; Liu A; Li X
Childs Nerv Syst; 2023 Dec; 39(12):3475-3482. PubMed ID: 37326845
[TBL] [Abstract][Full Text] [Related]
7. Impact of Rare and Multiple Concurrent Gene Fusions on Diagnostic DNA Methylation Classifier in Brain Tumors.
Galbraith K; Serrano J; Shen G; Tran I; Slocum CC; Ketchum C; Abdullaev Z; Turakulov R; Bale T; Ladanyi M; Sukhadia P; Zaidinski M; Mullaney K; DiNapoli S; Liechty BL; Barbaro M; Allen JC; Gardner SL; Wisoff J; Harter D; Hidalgo ET; Golfinos JG; Orringer DA; Aldape K; Benhamida J; Wrzeszczynski KO; Jour G; Snuderl M
Mol Cancer Res; 2024 Jan; 22(1):21-28. PubMed ID: 37870438
[TBL] [Abstract][Full Text] [Related]
8. Clinical rarity: simultaneous choroid plexus papilloma and extraventricular neurocytoma presenting as intraventricular hemorrhage in an adolescent.
Derouen K; Shelvin K; Shoap W; Craver R; Volk J; Roberts OA
J Surg Case Rep; 2024 Jan; 2024(1):rjad699. PubMed ID: 38213408
[TBL] [Abstract][Full Text] [Related]
9. Clinical, pathologic, and genomic characteristics of two pediatric glioneuronal tumors with a CLIP2::MET fusion.
Chapman N; Greenwald J; Suddock J; Xu D; Markowitz A; Humphrey M; Cotter JA; Krieger MD; Hawes D; Ji J
Acta Neuropathol Commun; 2024 Apr; 12(1):63. PubMed ID: 38650040
[TBL] [Abstract][Full Text] [Related]
10. Molecular and clinicopathologic characteristics of CNS embryonal tumors with BRD4::LEUTX fusion.
Andreiuolo F; Ferrone CK; Rajan S; Perry A; Guney E; Cham E; Giannini C; Toland A; Willard N; de Souza AS; Dazelle K; Chung HJ; Singh O; Conway K; Coley N; Dampier C; Abdullaev Z; Pratt D; Cimino PJ; Quezado M; Aldape K
Acta Neuropathol Commun; 2024 Mar; 12(1):42. PubMed ID: 38500181
[TBL] [Abstract][Full Text] [Related]
11. Central neurocytoma exhibits radial glial cell signatures with FGFR3 hypomethylation and overexpression.
Lee Y; Chowdhury T; Kim S; Yu HJ; Kim KM; Kang H; Kim MS; Kim JW; Kim YH; Ji SY; Hwang K; Han JH; Hwang J; Yoo SK; Lee KS; Choe G; Won JK; Park SH; Lee YK; Shin JH; Park CK; Kim CY; Kim JI
Exp Mol Med; 2024 Apr; 56(4):975-986. PubMed ID: 38609519
[TBL] [Abstract][Full Text] [Related]
12. DNA methylation analysis of glioblastomas harboring FGFR3-TACC3 fusions identifies a methylation subclass with better patient survival.
Wu Z; Lopes Abath Neto O; Bale TA; Benhamida J; Mata D; Turakulov R; Abdullaev Z; Marker D; Ketchum C; Chung HJ; Giannini C; Quezado M; Pratt D; Aldape K
Acta Neuropathol; 2022 Jul; 144(1):155-157. PubMed ID: 35567606
[No Abstract] [Full Text] [Related]
13. Brain Tumor Classification by Methylation Profile.
Park JW; Lee K; Kim EE; Kim SI; Park SH
J Korean Med Sci; 2023 Nov; 38(43):e356. PubMed ID: 37935168
[TBL] [Abstract][Full Text] [Related]
14. Clinicopathological and Molecular Profile of Sellar Neurocytoma.
Liu Y; Guo J; Cheng J; Fang Q; Wang D; Xie W; Li C
J Clin Endocrinol Metab; 2024 Apr; ():. PubMed ID: 38626164
[TBL] [Abstract][Full Text] [Related]
15. Analysis of a pituitary tumour with histological features of central neurocytoma points towards the emergence of a new entity recognizable by a specific epigenetic signature.
Godfraind C; Coutelier M; Pissaloux D; Forest F; Vandenbos F; Hasselblatt M; Boutonnat J; Coste A; Lantuejoul S; Mc Leer A
Neuropathol Appl Neurobiol; 2023 Dec; ():e12948. PubMed ID: 38112166
[No Abstract] [Full Text] [Related]
16. Rosette-forming glioneuronal tumors share a distinct DNA methylation profile and mutations in FGFR1, with recurrent co-mutation of PIK3CA and NF1.
Sievers P; Appay R; Schrimpf D; Stichel D; Reuss DE; Wefers AK; Reinhardt A; Coras R; Ruf VC; Schmid S; de Stricker K; Boldt HB; Kristensen BW; Petersen JK; Ulhøi BP; Gardberg M; Aronica E; Hasselblatt M; Brück W; Bielle F; Mokhtari K; Lhermitte B; Wick W; Herold-Mende C; Hänggi D; Brandner S; Giangaspero F; Capper D; Rushing E; Wesseling P; Pfister SM; Figarella-Branger D; von Deimling A; Sahm F; Jones DTW
Acta Neuropathol; 2019 Sep; 138(3):497-504. PubMed ID: 31250151
[TBL] [Abstract][Full Text] [Related]
17. cIMPACT-NOW update 4: diffuse gliomas characterized by MYB, MYBL1, or FGFR1 alterations or BRAF
Ellison DW; Hawkins C; Jones DTW; Onar-Thomas A; Pfister SM; Reifenberger G; Louis DN
Acta Neuropathol; 2019 Apr; 137(4):683-687. PubMed ID: 30848347
[No Abstract] [Full Text] [Related]
18. Myxoid glioneuronal tumor of the septum pellucidum and lateral ventricle is defined by a recurrent PDGFRA p.K385 mutation and DNT-like methylation profile.
Solomon DA; Korshunov A; Sill M; Jones DTW; Kool M; Pfister SM; Fan X; Bannykh S; Hu J; Danielpour M; Li R; Johnston J; Cham E; Cooney T; Sun PP; Oberheim Bush NA; McDermott M; Van Ziffle J; Onodera C; Grenert JP; Bastian BC; Villanueva-Meyer JE; Pekmezci M; Bollen AW; Perry A
Acta Neuropathol; 2018 Aug; 136(2):339-343. PubMed ID: 30006677
[No Abstract] [Full Text] [Related]
19. Distribution of EGFR amplification, combined chromosome 7 gain and chromosome 10 loss, and TERT promoter mutation in brain tumors and their potential for the reclassification of IDHwt astrocytoma to glioblastoma.
Stichel D; Ebrahimi A; Reuss D; Schrimpf D; Ono T; Shirahata M; Reifenberger G; Weller M; Hänggi D; Wick W; Herold-Mende C; Westphal M; Brandner S; Pfister SM; Capper D; Sahm F; von Deimling A
Acta Neuropathol; 2018 Nov; 136(5):793-803. PubMed ID: 30187121
[TBL] [Abstract][Full Text] [Related]
20. Advances in the classification of pediatric brain tumors through DNA methylation profiling: From research tool to frontline diagnostic.
Kumar R; Liu APY; Orr BA; Northcott PA; Robinson GW
Cancer; 2018 Nov; 124(21):4168-4180. PubMed ID: 30255939
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
